AAAAAA

   
Results: 1-18 |
Results: 18
Diagnosis and management of pre-core mutant chronic hepatitis B
Authors: Papatheodoridis, GV Hadziyannis, SJ
Citation: Gv. Papatheodoridis et Sj. Hadziyannis, Diagnosis and management of pre-core mutant chronic hepatitis B, J VIRAL HEP, 8(5), 2001, pp. 311-321
Autoimmune hepatitis associated with the antiphospholipid syndrome
Authors: Dourakis, SP Michael, AE Papanikolaou, IS Nomikou, E Thalassinou, P Hadziyannis, SJ
Citation: Sp. Dourakis et al., Autoimmune hepatitis associated with the antiphospholipid syndrome, EUR J GASTR, 13(5), 2001, pp. 591-593
Hepatitis B e antigen-negative chronic hepatitis B
Authors: Hadziyannis, SJ Vassilopoulos, D
Citation: Sj. Hadziyannis et D. Vassilopoulos, Hepatitis B e antigen-negative chronic hepatitis B, HEPATOLOGY, 34(4), 2001, pp. 617-624
Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.
Authors: Papatheodoridis, GV Papadimitropoulos, VC Hadziyannis, SJ
Citation: Gv. Papatheodoridis et al., Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis., ALIM PHARM, 15(5), 2001, pp. 689-698
Induction interferon therapy in nave patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit
Authors: Hadziyannis, AS Papaioannou, C Spanou, F Manesis, EK Hadziyannis, SJ
Citation: As. Hadziyannis et al., Induction interferon therapy in nave patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit, ALIM PHARM, 15(4), 2001, pp. 551-557
The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B
Authors: Papatheodoridis, GV Manesis, E Hadziyannis, SJ
Citation: Gv. Papatheodoridis et al., The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B, J HEPATOL, 34(2), 2001, pp. 306-313
Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection
Authors: Hadziyannis, SJ Vassilopoulos, D
Citation: Sj. Hadziyannis et D. Vassilopoulos, Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection, ANTIVIR RES, 52(2), 2001, pp. 91-98
Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B
Authors: Manesis, EK Hadziyannis, SJ
Citation: Ek. Manesis et Sj. Hadziyannis, Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B, GASTROENTY, 121(1), 2001, pp. 101-109
Complex management issues: management of HCV in the atypical patient
Authors: Hadziyannis, SJ Vassilopoulos, D
Citation: Sj. Hadziyannis et D. Vassilopoulos, Complex management issues: management of HCV in the atypical patient, BEST PR RES, 14(2), 2000, pp. 277-291
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature
Authors: Touzet, S Kraemer, L Colin, C Pradat, P Lanoir, D Bailly, F Coppola, RC Sauleda, S Thursz, MR Tillmann, H Alberti, A Braconier, JH Esteban, JI Hadziyannis, SJ Manns, MP Saracco, G Thomas, HC Trepo, C
Citation: S. Touzet et al., Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature, EUR J GASTR, 12(6), 2000, pp. 667-678
Gliclazide-induced acute hepatitis
Authors: Dourakis, SP Tzemanakis, E Sinani, C Kafiri, G Hadziyannis, SJ
Citation: Sp. Dourakis et al., Gliclazide-induced acute hepatitis, EUR J GASTR, 12(1), 2000, pp. 119-121
Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B
Authors: Hadziyannis, SJ Papatheodoridis, GV Dimou, E Laras, A Papaioannou, C
Citation: Sj. Hadziyannis et al., Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B, HEPATOLOGY, 32(4), 2000, pp. 847-851
Combination of interferon a therapy with non-steroidal anti-inflammatory drugs in chronic hepatitis C
Authors: Hadziyannis, SJ
Citation: Sj. Hadziyannis, Combination of interferon a therapy with non-steroidal anti-inflammatory drugs in chronic hepatitis C, GUT, 46(3), 2000, pp. 306-307
Prognostic factors determining the outcome of treatment in chronic hepatitis C
Authors: Hadziyannis, SJ
Citation: Sj. Hadziyannis, Prognostic factors determining the outcome of treatment in chronic hepatitis C, ACT GASTR B, 63(2), 2000, pp. 207-209
Long-term outcome of chronic hepatitis C treated with interferon
Authors: Hadziyannis, SJ Papatheodoridis, GV
Citation: Sj. Hadziyannis et Gv. Papatheodoridis, Long-term outcome of chronic hepatitis C treated with interferon, ITAL J GAST, 31(6), 1999, pp. 459-461
Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease
Authors: Dourakis, SP Tzemanakis, E Deutsch, M Kafiri, G Hadziyannis, SJ
Citation: Sp. Dourakis et al., Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease, EUR J GASTR, 11(9), 1999, pp. 1055-1058
Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilotstudy
Authors: Hadziyannis, SJ Manesis, EG Papakonstantinou, A
Citation: Sj. Hadziyannis et al., Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilotstudy, J HEPATOL, 31(2), 1999, pp. 210-214
Absence of the negative strand of GBV-C/HGV RNA from the liver
Authors: Laras, A Zacharakis, G Hadziyannis, SJ
Citation: A. Laras et al., Absence of the negative strand of GBV-C/HGV RNA from the liver, J HEPATOL, 30(3), 1999, pp. 383-388
Risultati: 1-18 |